Synthesis of the O antigen repeating units of Escherichia coli serotypes O117 and O107.

E. coli o107 Escherichia coli o117 Galnac-transferase L-rha-transferase

Journal

Glycobiology
ISSN: 1460-2423
Titre abrégé: Glycobiology
Pays: England
ID NLM: 9104124

Informations de publication

Date de publication:
20 Sep 2024
Historique:
received: 17 06 2024
revised: 19 08 2024
accepted: 18 09 2024
medline: 20 9 2024
pubmed: 20 9 2024
entrez: 20 9 2024
Statut: aheadofprint

Résumé

Escherichia coli serotype O117 (ECO117) are pathogenic bacteria that produce Shiga toxin. Repeating units of the O antigen of ECO117 have the pentasaccharide structure [4-D-GalNAcβ1-3-L-Rhaα1-4-D-Glcα1-4-D-Galβ1-3-D-GalNAcα1-]n. The related non-pathogenic serotype (ECO107) contains a GlcNAc residue instead of Glc in the repeating unit, and the biosynthetic enzymes involved are almost identical. We assembled these repeating units based on GalNAcα-diphosphate-phenylundecyl (GalNAcα-PP-PhU), an analog of the natural intermediate GalNAc-diphosphate-undecaprenyl. We previously characterized α1,4-Glc-transferase WclY from ECO117 that transfers the Glc residue to Galβ1-3GalNAcα-PP-PhU and showed that Arg194Cys mutants of WclY are active α1,4-GlcNAc-transferases. In this work, the reaction products of WclY were used as acceptor substrates for the final enzymes in pathway, L-Rha-transferase WclX, and GalNAc-transferase WclW, demonstrating a complete synthesis of the ECO117 and O107 repeating units. WclX transfers L-Rha with high specificity for the WclY enzyme product as the acceptor and for TDP-L-Rha as the donor substrate. A number of highly conserved sequence motifs were identified (DDGSxD, DxDD, and YR). Mutational analysis revealed several Asp residues are essential for the catalysis of L-Rha transfer, while mutations of Asp44 and R212 substantially reduced the activity of WclX. WclW is a GT2 enzyme specific for UDP-GalNAc but with broad specificity for the acceptor substrate. Using L-Rhaα-p-nitrophenyl as an acceptor for WclW, the reaction product was analyzed by NMR demonstrating that GalNAc was transferred in a β1-3 linkage to L-Rha. The in vitro synthesis of the repeating units allows the production of vaccine candidates and identifies potential targets for inhibition of O antigen biosynthesis.

Identifiants

pubmed: 39303140
pii: 7762899
doi: 10.1093/glycob/cwae074
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Dylan Falconer (D)

Department of Biomedical and Molecular Sciences, Queen's University, Kingston ON K7L3N6, Canada.

Jacob Melamed (J)

Department of Biomedical and Molecular Sciences, Queen's University, Kingston ON K7L3N6, Canada.

Alex Kocev (A)

Department of Biomedical and Molecular Sciences, Queen's University, Kingston ON K7L3N6, Canada.

Maike Bossert (M)

Department of Biomedical and Molecular Sciences, Queen's University, Kingston ON K7L3N6, Canada.

David L Jakeman (DL)

College of Pharmacy, Dalhousie University, Halifax NS, Canada.

Inka Brockhausen (I)

Department of Biomedical and Molecular Sciences, Queen's University, Kingston ON K7L3N6, Canada.

Classifications MeSH